logo.jpg
Zylö Therapeutics Closes $5.225 Million Series B Financing
June 03, 2022 09:00 ET | Zylö Therapeutics
GREENVILLE, SC, June 03, 2022 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., dedicated to developing a transformational drug-delivery platform, announced that it has raised $5.225 million in its Series...
logo.jpg
Zylö and Amifar Laboratorios Forge Broad-Ranging Partnership
May 19, 2021 09:00 ET | Zylö Therapeutics
The Z-pod™ delivery system will further enhance the ‘Science of Beauty’ GREENVILLE, SC, May 19, 2021 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical...
logo.jpg
Zylö and Grapefruit Forge Partnership That Promises to Disrupt the Topical Cannabis Market
July 28, 2020 10:00 ET | Zylö Therapeutics
The Z-pod™ delivery system will help make Hourglass™ by Grapefruit a game-changer GREENVILLE, SC, July 28, 2020 (GLOBE NEWSWIRE) -- Zylö Therapeutics Inc., developer of the transformational...
logo.jpg
Zylö and Hoth Therapeutics Forge Partnership to Develop Endocannabinoid-Based Drug to Treat Lupus
August 22, 2019 09:00 ET | Zylö Therapeutics
Zylö’s xerogel-derived delivery platform to be used to topically deliver the drug candidate Greenville, SC, Aug. 22, 2019 (GLOBE NEWSWIRE) -- Zylö Therapeutics, dedicated to bringing innovative...